BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16029657)

  • 1. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
    Lin Y; Wang SM; Huang RP
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
    Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME
    J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts.
    Kremmer T; Pälyi I; Daubner D; Boldizsár M; Vincze B; Paulik E; Sugár J; Pokorny E; Túry E
    Anticancer Res; 1991; 11(5):1807-13. PubMed ID: 1768053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression.
    Rosenauer A; Nervi C; Davison K; Lamph WW; Mader S; Miller WH
    Cancer Res; 1998 Nov; 58(22):5110-6. PubMed ID: 9823320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells.
    Sierra A; Price JE; García-Ramirez M; Méndez O; López L; Fabra A
    Lab Invest; 1997 Oct; 77(4):357-68. PubMed ID: 9354770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells.
    Gooch JL; Lee AV; Yee D
    Cancer Res; 1998 Sep; 58(18):4199-205. PubMed ID: 9751635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro.
    Rose DP; Connolly JM; Liu XH
    Cancer Res; 1994 Dec; 54(24):6557-62. PubMed ID: 7987856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human breast cancer cells and normal mammary epithelial cells: retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol.
    Chen AC; Guo X; Derguini F; Gudas LJ
    Cancer Res; 1997 Oct; 57(20):4642-51. PubMed ID: 9377581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human breast cancer progression can be regulated by dominant trans-acting factors in somatic cell hybridization studies.
    Safarians S; Sternlicht MD; Yamanishi DT; Love SM; Barsky SH
    Cancer Res; 1996 Aug; 56(15):3560-9. PubMed ID: 8758927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards endothelial-cell-directed cancer immunotherapy: in vitro expression of human recombinant cytokine genes by human and mouse primary endothelial cells.
    Ojeifo JO; Su N; Ryan US; Verma UN; Mazumder A; Zwiebel JA
    Cytokines Mol Ther; 1996 Jun; 2(2):89-101. PubMed ID: 9384693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines.
    Chiu JJ; Sgagias MK; Cowan KH
    Clin Cancer Res; 1996 Jan; 2(1):215-21. PubMed ID: 9816109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells.
    Delehedde M; Deudon E; Boilly B; Hondermarck H
    Exp Cell Res; 1996 Dec; 229(2):398-406. PubMed ID: 8986623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroids and medroxyprogesterone acetate inhibit the induction of E-selectin on the vascular endothelium by MDA-MB-231 breast cancer cells.
    Narita T; Kawakami-Kimura N; Matsuura N; Hosono J; Kannagi R
    Anticancer Res; 1995; 15(6B):2523-7. PubMed ID: 8669817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of selenium-dependent glutathione peroxidase in human breast tumor cell lines.
    Esworthy RS; Baker MA; Chu FF
    Cancer Res; 1995 Feb; 55(4):957-62. PubMed ID: 7850813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro estradiol-sensitivity characterization of the MCF-7, ZR-75, MDA-MB-231 and T47-D human breast neoplastic cell lines.
    Camby I; Kiss R
    Anticancer Res; 1993; 13(6A):2355-60. PubMed ID: 8297158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of a heregulin-like growth factor secreted by estrogen receptor-negative MDA-MB-231 human breast cancer cells that stimulates estrogen receptor-positive cells.
    Küng W; David F; Langen H; Weyer KA; Schlaeger EJ; Lahm HW; Silber E; Mueller H; Eppenberger U
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1357-65. PubMed ID: 8060314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
    Levi-Schaffer F; Segal V; Barak V; Rubinchik E; Nagler A
    Exp Hematol; 1997 Mar; 25(3):238-45. PubMed ID: 9091300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells.
    Hurd C; Khattree N; Dinda S; Alban P; Moudgil VK
    Oncogene; 1997 Aug; 15(8):991-5. PubMed ID: 9285694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of acidic and basic fibroblast growth factor by the hormone-independent breast cancer cell line MDA-MB-231.
    el Yazidi I; Boilly-Marer Y
    Anticancer Res; 1995; 15(3):783-90. PubMed ID: 7544091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.